| EMA number | EMEA/H/C/004836 |
| ATC code | R03AL09 |
| Authorisation | 23 April 2018 |
| Withdrawn | 6 March 2025 |
| Revision | 7 |
Maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist (for effects on symptoms control and prevention of exacerbations see section 5.1).